Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Atypical and aggressive ulcers are associated with aspirin abuse

Patients with aspirin abuse have atypical, often multiple, intractable ulcers with many complications, according to research published in the May/June issue of the Journal of Clinical Gastroenterology.

News image

fiogf49gjkf04

Researchers from Birmingham, Alabama, USA, evaluated atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse.

Unusual resistance to treatment in 5% to 7% of 1845 peptic ulcers, examined under endoscopy from 1987 to 1996, prompted a search for unusual causes.

Although Zollinger-Ellison syndrome (ZES) caused some of these ulcers, an atypical clinical course in other patients, especially with those with multiple ulcers, suggested abuse of aspirin.

Patients who did not have ZES were questioned closely regarding aspirin use. They were also tested for serum salicylate to detect surreptitious abuse.

The authors identified 37 patients (12 men and 25 women, aged 18 to 73 years) with aspirin-related ulcers, but otherwise intact upper gastrointestinal tracts.

Of these, 18 admitted to current aspirin abuse (> 1 g/day). However, 19 denied it, despite objective evidence from elevated serum salicylate (8.4 mg/dl).

Ulcers remain incurable and dangerous if aspirin abuse is not stopped.
Journal of Clinical Gastroenterology
The clinical presentation was atypical, with only 10 patients having single ulcers, whereas 27 had 83 multiple or multiorgan ulcers.

Overall, there were 32 duodenal, 57 gastric, and 4 esophageal ulcers.

Omeprazole healed 64% of ulcers. However, despite follow-up maintenance with H2 receptor antagonists, all ulcers recurred rapidly, often in a new location.

Of the patients, 30 had serious complications: 18 bled; 9 had pyloric and 2 had duodenal stenosis; 2 had esophageal strictures; and 2 had perforation.

Six patients who stopped using aspirin healed easily.

The 80% who did not stop on advice after diagnosis were considered abusers.

Dr Basil I. Hirschowitz, of the University of Alabama at Birmingham, said on behalf of his colleagues, "Patients with aspirin abuse have atypical, often multiple, intractable ulcers with many complications."

"These ulcers differ from conventional Helicobacter pylori peptic ulcers and also from those found in patients with ZES," he added.

"Unless aspirin use is stopped, these ulcers remain incurable and dangerous," he concluded.

J Clin Gastroenterol 2002; 34 (5): 523-8
23 April 2002

Go to top of page Email this page Email this page to a colleague

 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us